Safety of amisulpride in combination with antidepressants under common clinical practice conditions.

Aim: The main objective was to identify the occurrence of adverse events associated with amisulpride when combined with antidepressants (ADs).

Methods: A non-interventional questionnaire-based study focussed on identification of occurrence and tolerance of combinations of amisulpride with ADs under common clinical practice conditions.

Results: Combinations of amisulpride with ADs were administered to 3178 patients suffering from depression.